Yat Sun Or

Person

Libertyville, IL, US

People

Patents Grantslast 30 patents

Information Patent Grant
Spiropyrrolidine derived antiviral agents
- Patent number 12,145,942
- Issue date Nov 19, 2024
- Enanta Pharmaceuticals, Inc.
- Hui Cao
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Heterocyclic antiviral agents
- Patent number 12,145,941
- Issue date Nov 19, 2024
- Enanta Pharmaceuticals, Inc.
- Joseph D. Panarese
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Hepatitis B antiviral agents
- Patent number 12,054,493
- Issue date Aug 6, 2024
- Enanta Pharmaceuticals, Inc.
- Yao-Ling Qiu
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Apoptosis signal-regulating kinase 1 inhibitors and methods of use...
- Patent number 12,018,017
- Issue date Jun 25, 2024
- Enanta Pharmaceuticals, Inc.
- Guoqiang Wang
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Hepatitis B antiviral agents
- Patent number 12,011,425
- Issue date Jun 18, 2024
- Enanta Pharmaceuticals, Inc.
- Yao-Ling Qiu
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Antiviral heterocyclic compounds
- Patent number 12,006,326
- Issue date Jun 11, 2024
- Enanta Pharmaceuticals, Inc.
- Adam Szymaniak
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Processes for the preparation of 4,6,7-trifluoro-1H-indole-2-carbox...
- Patent number 12,006,291
- Issue date Jun 11, 2024
- Enanta Pharmaceuticals, Inc.
- Kaicheng Zhu
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Saturated spirocyclics as antiviral agents
- Patent number 11,993,600
- Issue date May 28, 2024
- Enanta Pharmaceuticals, Inc.
- Joseph D. Panarese
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Spiropyrrolidine derived antiviral agents
- Patent number 11,976,084
- Issue date May 7, 2024
- Enanta Pharmaceuticals, Inc.
- Guoqiang Wang
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Macrocyclic antiviral agents
- Patent number 11,970,502
- Issue date Apr 30, 2024
- Enanta Pharmaceuticals, Inc.
- Jiajun Zhang
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Bile acid derivatives as FXR/TGR5 agonists and methods of use thereof
- Patent number 11,958,879
- Issue date Apr 16, 2024
- Enanta Pharmaceuticals, Inc.
- Guoqiang Wang
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Benzodiazepine derivatives as RSV inhibitors
- Patent number 11,952,389
- Issue date Apr 9, 2024
- Enanta Pharmaceuticals, Inc.
- Brian C. Shook
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Antiviral heterocyclic compounds
- Patent number 11,945,830
- Issue date Apr 2, 2024
- Enanta Pharmaceuticals, Inc.
- Adam Szymaniak
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Heterocyclic compounds as anti-viral agents
- Patent number 11,945,824
- Issue date Apr 2, 2024
- Enanta Pharmaceuticals, Inc.
- Yat Sun Or
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Spiropyrrolidine derived antiviral agents
- Patent number 11,919,910
- Issue date Mar 5, 2024
- Enanta Pharmaceuticals, Inc.
- Guoqiang Wang
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Spiropyrrolidine derived antiviral agents
- Patent number 11,912,714
- Issue date Feb 27, 2024
- Enanta Pharmaceuticals, Inc.
- Hui Cao
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Benzodiazepine derivatives as RSV inhibitors
- Patent number 11,912,695
- Issue date Feb 27, 2024
- Enanta Pharmaceuticals, Inc.
- Kaicheng Zhu
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Functionalized heterocycles as antiviral agents
- Patent number 11,891,393
- Issue date Feb 6, 2024
- Enanta Pharmaceuticals, Inc.
- Joseph Panarese
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Alkyne-containing antiviral agents
- Patent number 11,858,945
- Issue date Jan 2, 2024
- Enanta Pharmaceuticals, Inc.
- Joseph D. Panarese
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Tetrazole containing apoptosis signal-regulating kinase 1 inhibitor...
- Patent number 11,834,436
- Issue date Dec 5, 2023
- Enanta Pharmaceuticals, Inc.
- Guoqiang Wang
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Functionalized heterocyclic compounds as antiviral agents
- Patent number 11,802,125
- Issue date Oct 31, 2023
- Joseph D. Panarese
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Hepatitis B antiviral agents
- Patent number 11,760,755
- Issue date Sep 19, 2023
- Enanta Pharmaceuticals, Inc.
- Yao-Ling Qiu
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
EIF4E inhibitors and uses thereof
- Patent number 11,753,403
- Issue date Sep 12, 2023
- PIC Therapeutics, Inc.
- Christopher L. Vandeusen
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Substituted heterocycles as antiviral agents
- Patent number 11,738,019
- Issue date Aug 29, 2023
- Enanta Pharmaceuticals, Inc.
- Joseph Panarese
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Bile acid derivatives as FXR/TGR5 agonists and methods of use thereof
- Patent number 11,718,641
- Issue date Aug 8, 2023
- Enanta Pharmaceuticals, Inc.
- Guoqiang Wang
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Hepatitis B antiviral agents
- Patent number 11,596,611
- Issue date Mar 7, 2023
- Enanta Pharmaceuticals, Inc.
- Yao-Ling Qiu
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Tetrazole derivatives of bile acids as FXR/TGR5 agonists and method...
- Patent number 11,578,097
- Issue date Feb 14, 2023
- Enanta Pharmaceuticals, Inc.
- Yat Sun Or
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Antiviral heterocyclic compounds
- Patent number 11,572,367
- Issue date Feb 7, 2023
- Enanta Pharmaceuticals, Inc.
- Adam Szymaniak
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Apoptosis signal-regulating kinase 1 inhibitors and methods of use...
- Patent number 11,560,368
- Issue date Jan 24, 2023
- Enanta Pharmaceuticals, Inc.
- Guoqiang Wang
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Isoxazole derivatives as FXR agonists and methods of use thereof
- Patent number 11,555,032
- Issue date Jan 17, 2023
- Enanta Pharmaceuticals, Inc.
- Guoqiang Wang
- C07 - ORGANIC CHEMISTRY

Patents Applicationslast 30 patents

Information Patent Application
Apoptosis Signal-Regulating Kinase 1 Inhibitors and Methods of Use...
- Publication number 20240376079
- Publication date Nov 14, 2024
- Enanta Pharmaceuticals, Inc.
- Guoqiang Wang
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Hepatitis B Antiviral Agents
- Publication number 20240366538
- Publication date Nov 7, 2024
- Enanta Pharmaceuticals, Inc.
- Yao-Ling Qiu
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Antiviral Heterocyclic Compounds
- Publication number 20240368174
- Publication date Nov 7, 2024
- Enanta Pharmaceuticals, Inc.
- Adam Szymaniak
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
BENZODIAZEPINE DERIVATIVES AS RSV INHIBITORS
- Publication number 20240360117
- Publication date Oct 31, 2024
- Enanta Pharmaceuticals, Inc.
- Kaicheng Zhu
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Benzodiazepine Derivatives as RSV Inhibitors
- Publication number 20240360155
- Publication date Oct 31, 2024
- Enanta Pharmaceuticals, Inc.
- Brian C. Shook
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Covalent Inhibitors As Antiviral Agents
- Publication number 20240327334
- Publication date Oct 3, 2024
- Enanta Pharmaceuticals, Inc.
- Xuri GAO
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Fused Heterotetracyclic Antiviral Agents
- Publication number 20240325409
- Publication date Oct 3, 2024
- Enanta Pharmaceuticals, Inc.
- Sean RAFFERTY
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Bile Acid Derivatives as FXR/TGR5 Agonists and Methods of Use Thereof
- Publication number 20240327452
- Publication date Oct 3, 2024
- Enanta Pharmaceuticals, Inc.
- Guoqiang Wang
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Functionalized Heterocycles as Antiviral Agents
- Publication number 20240262828
- Publication date Aug 8, 2024
- Enanta Pharmaceuticals, Inc.
- Joseph D. PANARESE
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
TETRAZOLE CONTAINING APOPTOSIS SIGNAL-REGULATING KINASE 1 INHIBITOR...
- Publication number 20240228464
- Publication date Jul 11, 2024
- Enanta Pharmaceuticals, Inc.
- Guoqiang Wang
- C07 - ORGANIC CHEMISTRY
Information Patent Application
MACROCYCLIC CHALCONE-AMIDE DERIVED ANTIVIRAL AGENTS
- Publication number 20240207224
- Publication date Jun 27, 2024
- Enanta Pharmaceuticals, Inc.
- Jiajun Zhang
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
BILE ACID DERIVATIVES AS FXR/TGR5 AGONISTS AND METHODS OF USE THEREOF
- Publication number 20240140984
- Publication date May 2, 2024
- Enanta Pharmaceuticals, Inc.
- Guoqiang Wang
- C07 - ORGANIC CHEMISTRY
Information Patent Application
FUSED HETEROBICYCLIC ANTIVIRAL AGENTS
- Publication number 20240140922
- Publication date May 2, 2024
- Enanta Pharmaceuticals, Inc.
- Samuel Bartlett
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
TETRAZOLE CONTAINING APOPTOSIS SIGNAL-REGULATING KINASE 1 INHIBITOR...
- Publication number 20240132476
- Publication date Apr 25, 2024
- Enanta Pharmaceuticals, Inc.
- Guoqiang Wang
- C07 - ORGANIC CHEMISTRY
Information Patent Application
CRYSTAL FORMS OF AN ANTI-SARS COV-2 AGENT
- Publication number 20240132512
- Publication date Apr 25, 2024
- Enanta Pharmaceuticals, Inc.
- Kaicheng Zhu
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
PYRIMIDINONE-CONTAINING 17-BETA-HYDROXYSTEROID DEHYDROGENASE TYPE 1...
- Publication number 20230416268
- Publication date Dec 28, 2023
- Enanta Pharmaceuticals, Inc.
- Yat Sun Or
- C07 - ORGANIC CHEMISTRY
Information Patent Application
EIF4E INHIBITORS AND USES THEREOF
- Publication number 20230399322
- Publication date Dec 14, 2023
- PIC Therapeutics, Inc.
- Christopher L. VANDEUSEN
- C07 - ORGANIC CHEMISTRY
Information Patent Application
ANTIVIRAL COMPOUNDS
- Publication number 20230365525
- Publication date Nov 16, 2023
- Enanta Pharmaceuticals, Inc.
- Jianming Yu
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ANTIVIRAL HETEROCYCLIC COMPOUNDS
- Publication number 20230357258
- Publication date Nov 9, 2023
- Enanta Pharmaceuticals, Inc.
- Adam Szymaniak
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
NOVEL SPIROPYRROLIDINE DERIVED ANTIVIRAL AGENTS
- Publication number 20230331734
- Publication date Oct 19, 2023
- Enanta Pharmaceuticals, Inc.
- Hui Cao
- C07 - ORGANIC CHEMISTRY
Information Patent Application
PROCESSES FOR THE PREPARATION OF SUBSTITUTED SPIROOXINDOLE DERIVATIVES
- Publication number 20230295175
- Publication date Sep 21, 2023
- Enanta Pharmaceuticals, Inc.
- Kaicheng Zhu
- C07 - ORGANIC CHEMISTRY
Information Patent Application
HEPATITIS B ANTIVIRAL AGENTS
- Publication number 20230241012
- Publication date Aug 3, 2023
- Enanta Pharmaceuticals, Inc.
- Yao-Ling Qiu
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
PROCESSES FOR THE PREPARATION OF 4,6,7-TRIFLUORO-1H-INDOLE-2-CARBOX...
- Publication number 20230234922
- Publication date Jul 27, 2023
- Enanta Pharmaceuticals, Inc.
- Kaicheng Zhu
- C07 - ORGANIC CHEMISTRY
Information Patent Application
SPIROPYRROLIDINE DERIVED ANTIVIRAL AGENTS
- Publication number 20230203048
- Publication date Jun 29, 2023
- Enanta Pharmaceuticals, Inc.
- Guoqiang Wang
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
HETEROCYCLIC ANTIVIRAL AGENTS
- Publication number 20230174542
- Publication date Jun 8, 2023
- Enanta Pharmaceuticals, Inc.
- Joseph D. Panarese
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
SATURATED SPIROCYCLICS AS ANTIVIRAL AGENTS
- Publication number 20230174531
- Publication date Jun 8, 2023
- Enanta Pharmaceuticals, Inc.
- Joseph D. Panarese
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
APOPTOSIS SIGNAL-REGULATING KINASE 1 INHIBITORS AND METHODS OF USE...
- Publication number 20230174515
- Publication date Jun 8, 2023
- Enanta Pharmaceuticals, Inc.
- Guoqiang Wang
- C07 - ORGANIC CHEMISTRY
Information Patent Application
ALKYNE-CONTAINING ANTIVIRAL AGENTS
- Publication number 20230159545
- Publication date May 25, 2023
- Enanta Pharmaceuticals, Inc.
- Joseph D. Panarese
- C07 - ORGANIC CHEMISTRY
Information Patent Application
NOVEL SPIROPYRROLIDINE DERIVED ANTIVIRAL AGENTS
- Publication number 20230159546
- Publication date May 25, 2023
- Enanta Pharmaceuticals, Inc.
- Jorden Kass
- C07 - ORGANIC CHEMISTRY
Information Patent Application
NOVEL SPIROPYRROLIDINE DERIVED ANTIVIRAL AGENTS
- Publication number 20230151019
- Publication date May 18, 2023
- Enanta Pharmaceuticals, Inc.
- Hui Cao
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Person

Patents Grantslast 30 patents

Spiropyrrolidine derived antiviral agents

Heterocyclic antiviral agents

Hepatitis B antiviral agents

Apoptosis signal-regulating kinase 1 inhibitors and methods of use...

Hepatitis B antiviral agents

Antiviral heterocyclic compounds

Processes for the preparation of 4,6,7-trifluoro-1H-indole-2-carbox...

Saturated spirocyclics as antiviral agents

Spiropyrrolidine derived antiviral agents

Macrocyclic antiviral agents

Bile acid derivatives as FXR/TGR5 agonists and methods of use thereof

Benzodiazepine derivatives as RSV inhibitors

Antiviral heterocyclic compounds

Heterocyclic compounds as anti-viral agents

Spiropyrrolidine derived antiviral agents

Spiropyrrolidine derived antiviral agents

Benzodiazepine derivatives as RSV inhibitors

Functionalized heterocycles as antiviral agents

Alkyne-containing antiviral agents

Tetrazole containing apoptosis signal-regulating kinase 1 inhibitor...

Functionalized heterocyclic compounds as antiviral agents

Hepatitis B antiviral agents

EIF4E inhibitors and uses thereof

Substituted heterocycles as antiviral agents

Bile acid derivatives as FXR/TGR5 agonists and methods of use thereof

Hepatitis B antiviral agents

Tetrazole derivatives of bile acids as FXR/TGR5 agonists and method...

Antiviral heterocyclic compounds

Apoptosis signal-regulating kinase 1 inhibitors and methods of use...

Isoxazole derivatives as FXR agonists and methods of use thereof

Patents Applicationslast 30 patents

Apoptosis Signal-Regulating Kinase 1 Inhibitors and Methods of Use...

Hepatitis B Antiviral Agents

Antiviral Heterocyclic Compounds

BENZODIAZEPINE DERIVATIVES AS RSV INHIBITORS

Benzodiazepine Derivatives as RSV Inhibitors

Covalent Inhibitors As Antiviral Agents

Fused Heterotetracyclic Antiviral Agents

Bile Acid Derivatives as FXR/TGR5 Agonists and Methods of Use Thereof

Functionalized Heterocycles as Antiviral Agents

TETRAZOLE CONTAINING APOPTOSIS SIGNAL-REGULATING KINASE 1 INHIBITOR...

MACROCYCLIC CHALCONE-AMIDE DERIVED ANTIVIRAL AGENTS

BILE ACID DERIVATIVES AS FXR/TGR5 AGONISTS AND METHODS OF USE THEREOF

FUSED HETEROBICYCLIC ANTIVIRAL AGENTS

TETRAZOLE CONTAINING APOPTOSIS SIGNAL-REGULATING KINASE 1 INHIBITOR...

CRYSTAL FORMS OF AN ANTI-SARS COV-2 AGENT

PYRIMIDINONE-CONTAINING 17-BETA-HYDROXYSTEROID DEHYDROGENASE TYPE 1...

EIF4E INHIBITORS AND USES THEREOF

ANTIVIRAL COMPOUNDS

ANTIVIRAL HETEROCYCLIC COMPOUNDS

NOVEL SPIROPYRROLIDINE DERIVED ANTIVIRAL AGENTS

PROCESSES FOR THE PREPARATION OF SUBSTITUTED SPIROOXINDOLE DERIVATIVES

HEPATITIS B ANTIVIRAL AGENTS

PROCESSES FOR THE PREPARATION OF 4,6,7-TRIFLUORO-1H-INDOLE-2-CARBOX...

SPIROPYRROLIDINE DERIVED ANTIVIRAL AGENTS

HETEROCYCLIC ANTIVIRAL AGENTS

SATURATED SPIROCYCLICS AS ANTIVIRAL AGENTS

APOPTOSIS SIGNAL-REGULATING KINASE 1 INHIBITORS AND METHODS OF USE...

ALKYNE-CONTAINING ANTIVIRAL AGENTS

NOVEL SPIROPYRROLIDINE DERIVED ANTIVIRAL AGENTS

NOVEL SPIROPYRROLIDINE DERIVED ANTIVIRAL AGENTS